vs

Side-by-side financial comparison of AXT INC (AXTI) and BIOLIFE SOLUTIONS INC (BLFS). Click either name above to swap in a different company.

AXT INC is the larger business by last-quarter revenue ($26.9M vs $18.8M, roughly 1.4× BIOLIFE SOLUTIONS INC). On growth, AXT INC posted the faster year-over-year revenue change (39.1% vs 24.3%). Over the past eight quarters, BIOLIFE SOLUTIONS INC's revenue compounded faster (1.0% CAGR vs -1.8%).

AXT Inc designs, manufactures and sells high-performance compound semiconductor substrates, including gallium arsenide, indium phosphide and germanium wafers. Its products power optoelectronic and radio frequency devices for global communications, consumer electronics and industrial end markets.

Biolife Solutions Inc. develops, manufactures and distributes specialized biopreservation products and cold chain management solutions for the cell and gene therapy, biopharmaceutical and regenerative medicine industries. It offers cryopreservation media, automated thawing systems, and temperature monitoring tools, serving biotech firms, research institutions and clinical labs globally.

AXTI vs BLFS — Head-to-Head

Bigger by revenue
AXTI
AXTI
1.4× larger
AXTI
$26.9M
$18.8M
BLFS
Growing faster (revenue YoY)
AXTI
AXTI
+14.8% gap
AXTI
39.1%
24.3%
BLFS
Faster 2-yr revenue CAGR
BLFS
BLFS
Annualised
BLFS
1.0%
-1.8%
AXTI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AXTI
AXTI
BLFS
BLFS
Revenue
$26.9M
$18.8M
Net Profit
$11.1M
Gross Margin
29.6%
Operating Margin
64.5%
7.2%
Net Margin
58.9%
Revenue YoY
39.1%
24.3%
Net Profit YoY
-11.1%
EPS (diluted)
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXTI
AXTI
BLFS
BLFS
Q1 26
$26.9M
Q4 25
$23.0M
$18.8M
Q3 25
$28.0M
$28.1M
Q2 25
$18.0M
$25.4M
Q1 25
$19.4M
$23.9M
Q4 24
$25.1M
$15.1M
Q3 24
$23.6M
$21.4M
Q2 24
$27.9M
$19.7M
Net Profit
AXTI
AXTI
BLFS
BLFS
Q1 26
Q4 25
$-3.5M
$11.1M
Q3 25
$-1.9M
$621.0K
Q2 25
$-7.0M
$-15.8M
Q1 25
$-8.8M
$-448.0K
Q4 24
$-5.1M
$12.5M
Q3 24
$-2.9M
$-1.7M
Q2 24
$-1.5M
$-20.7M
Gross Margin
AXTI
AXTI
BLFS
BLFS
Q1 26
29.6%
Q4 25
20.9%
Q3 25
22.3%
Q2 25
8.0%
Q1 25
-6.4%
Q4 24
17.6%
Q3 24
24.0%
Q2 24
27.4%
Operating Margin
AXTI
AXTI
BLFS
BLFS
Q1 26
64.5%
Q4 25
-16.6%
7.2%
Q3 25
-4.0%
-0.3%
Q2 25
-37.5%
-65.5%
Q1 25
-53.1%
-5.1%
Q4 24
-24.6%
3.6%
Q3 24
-14.4%
-2.0%
Q2 24
-6.8%
-6.6%
Net Margin
AXTI
AXTI
BLFS
BLFS
Q1 26
Q4 25
-15.4%
58.9%
Q3 25
-6.8%
2.2%
Q2 25
-39.0%
-62.3%
Q1 25
-45.5%
-1.9%
Q4 24
-20.3%
82.5%
Q3 24
-12.4%
-8.0%
Q2 24
-5.4%
-105.1%
EPS (diluted)
AXTI
AXTI
BLFS
BLFS
Q1 26
Q4 25
$-0.09
$0.23
Q3 25
$-0.04
$0.01
Q2 25
$-0.16
$-0.33
Q1 25
$-0.20
$-0.01
Q4 24
$-0.11
$0.27
Q3 24
$-0.07
$-0.04
Q2 24
$-0.04
$-0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXTI
AXTI
BLFS
BLFS
Cash + ST InvestmentsLiquidity on hand
$107.1M
$33.0M
Total DebtLower is stronger
$5.0M
Stockholders' EquityBook value
$298.4M
$371.9M
Total Assets
$444.6M
$405.9M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXTI
AXTI
BLFS
BLFS
Q1 26
$107.1M
Q4 25
$120.3M
$33.0M
Q3 25
$23.1M
$29.5M
Q2 25
$27.0M
$31.9M
Q1 25
$31.6M
$66.9M
Q4 24
$22.8M
$91.5M
Q3 24
$24.9M
$24.0M
Q2 24
$29.5M
$22.0M
Total Debt
AXTI
AXTI
BLFS
BLFS
Q1 26
Q4 25
$5.0M
Q3 25
$7.5M
Q2 25
$10.1M
Q1 25
$12.9M
Q4 24
$15.9M
Q3 24
$20.1M
Q2 24
$21.1M
Stockholders' Equity
AXTI
AXTI
BLFS
BLFS
Q1 26
$298.4M
Q4 25
$273.3M
$371.9M
Q3 25
$179.1M
$353.7M
Q2 25
$179.7M
$347.2M
Q1 25
$185.0M
$352.6M
Q4 24
$192.8M
$348.9M
Q3 24
$200.7M
$325.5M
Q2 24
$199.7M
$321.4M
Total Assets
AXTI
AXTI
BLFS
BLFS
Q1 26
$444.6M
Q4 25
$433.8M
$405.9M
Q3 25
$334.0M
$392.1M
Q2 25
$329.0M
$387.2M
Q1 25
$333.5M
$395.1M
Q4 24
$339.3M
$399.5M
Q3 24
$355.6M
$381.7M
Q2 24
$349.4M
$375.0M
Debt / Equity
AXTI
AXTI
BLFS
BLFS
Q1 26
Q4 25
0.01×
Q3 25
0.02×
Q2 25
0.03×
Q1 25
0.04×
Q4 24
0.05×
Q3 24
0.06×
Q2 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXTI
AXTI
BLFS
BLFS
Operating Cash FlowLast quarter
$4.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.44×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXTI
AXTI
BLFS
BLFS
Q1 26
Q4 25
$4.3M
$4.9M
Q3 25
$-9.2M
$6.1M
Q2 25
$-4.6M
$7.4M
Q1 25
$-3.3M
$1.7M
Q4 24
$1.3M
$1.6M
Q3 24
$-5.4M
$4.8M
Q2 24
$843.0K
$6.5M
Free Cash Flow
AXTI
AXTI
BLFS
BLFS
Q1 26
Q4 25
$1.3M
Q3 25
$-11.3M
Q2 25
$-4.9M
Q1 25
$-3.9M
Q4 24
$1.1M
Q3 24
$-6.4M
Q2 24
$572.0K
FCF Margin
AXTI
AXTI
BLFS
BLFS
Q1 26
Q4 25
5.5%
Q3 25
-40.5%
Q2 25
-27.0%
Q1 25
-19.9%
Q4 24
4.4%
Q3 24
-26.9%
Q2 24
2.0%
Capex Intensity
AXTI
AXTI
BLFS
BLFS
Q1 26
Q4 25
13.2%
Q3 25
7.8%
Q2 25
1.6%
Q1 25
2.6%
Q4 24
0.7%
Q3 24
4.0%
Q2 24
1.0%
Cash Conversion
AXTI
AXTI
BLFS
BLFS
Q1 26
Q4 25
0.44×
Q3 25
9.83×
Q2 25
Q1 25
Q4 24
0.13×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons